"68Ga-Trivehexin" by Johannes Notni & Jakub Simecek + Q&A - EANM'22 Symposium Part 5 of 5
ฝัง
- เผยแพร่เมื่อ 15 ต.ค. 2024
- Part 5 of 5 in our EANM'22 Satellite Symposium "Theranostic Innovations" which was held in Barcelona on October 18, 2022.
In this talk, Johannes Notni and Jakub Simecek talk about TRIMT's 68Ga-Trivehexin as an imaging agent for different applications and its way into clinics.
You'll find the other parts here:
Part 1 - Theranostics Roadmap: The Long or the Short Way from Therapeutic to Diagnostic ( • "Theranostic Roadmap" ... )
Part 2 - CXCR4 Based Theranostics for Marginal Zone Lymphoma and Other Hematological Neoplasms (Link on request from marketing.medical@ezag.de)
Part 3 - CXCR4 Based Theranostics for Multiple Myeloma and Leukemia + CXCR4 Q&A (Link on request from marketing.medical@ezag.de)
Part 4 - Radiolabeled Single Domain Antibodies as Theranostic Tools in Oncology ( • "Radiolabeled Single-D... )
For more information visit www.medical.ezag.com or contact us at marketing.medical@ezag.de
